Business Standard

Monday, December 23, 2024 | 05:22 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Don't count too much on Covid-19 vaccine, warn Powell and Lagarde

On Monday, the pharmaceutical company Pfizer announced encouraging results from its vaccine trials, nudging stock markets toward new heights

Christine Lagarde
Premium

Lagarde, explaining that she did not want to be “exuberant” about the treatment, also pointed to uncertainties — about the logistics, and about how many people will actually be vaccinated in 2021

Jeanna Smialek, Emily Cochrane, Nicholas Fandos & Alan Rappeport | NYT Washington
Two of the world’s most powerful central bankers said on Thursday that economic risks from the coronavirus remain high, and they cautioned against putting too much faith in a quick fix from a vaccine, delivering a sober message as US lawmakers signalled that another stimulus package was unlikely before year’s end.

“The next few months could be challenging,” Federal Reserve Chair Jerome H Powell said during a webcast panel discussion, where he appeared alongside his European counterparts. Both Powell and Christine Lagarde, head of the European Central Bank, warned that while recent progress toward a vaccine was welcome news, it was

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in